20-48952689-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006420.3(ARFGEF2):​c.424-16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0598 in 1,613,286 control chromosomes in the GnomAD database, including 3,267 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.047 ( 191 hom., cov: 32)
Exomes 𝑓: 0.061 ( 3076 hom. )

Consequence

ARFGEF2
NM_006420.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.60

Publications

5 publications found
Variant links:
Genes affected
ARFGEF2 (HGNC:15853): (ADP ribosylation factor guanine nucleotide exchange factor 2) ADP-ribosylation factors (ARFs) play an important role in intracellular vesicular trafficking. The protein encoded by this gene is involved in the activation of ARFs by accelerating replacement of bound GDP with GTP and is involved in Golgi transport. It contains a Sec7 domain, which may be responsible for its guanine-nucleotide exchange activity and also brefeldin A inhibition. [provided by RefSeq, Jul 2008]
ARFGEF2 Gene-Disease associations (from GenCC):
  • periventricular heterotopia with microcephaly, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • periventricular nodular heterotopia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 20-48952689-C-T is Benign according to our data. Variant chr20-48952689-C-T is described in ClinVar as Benign. ClinVar VariationId is 136418.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0955 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARFGEF2NM_006420.3 linkc.424-16C>T intron_variant Intron 4 of 38 ENST00000371917.5 NP_006411.2 Q9Y6D5Q86TH5Q59FR3
ARFGEF2NM_001410846.1 linkc.424-16C>T intron_variant Intron 4 of 38 NP_001397775.1
ARFGEF2XM_047439832.1 linkc.-141-16C>T intron_variant Intron 2 of 36 XP_047295788.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARFGEF2ENST00000371917.5 linkc.424-16C>T intron_variant Intron 4 of 38 1 NM_006420.3 ENSP00000360985.4 Q9Y6D5

Frequencies

GnomAD3 genomes
AF:
0.0473
AC:
7192
AN:
152136
Hom.:
192
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0120
Gnomad AMI
AF:
0.0187
Gnomad AMR
AF:
0.0387
Gnomad ASJ
AF:
0.0951
Gnomad EAS
AF:
0.0813
Gnomad SAS
AF:
0.103
Gnomad FIN
AF:
0.0347
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0637
Gnomad OTH
AF:
0.0533
GnomAD2 exomes
AF:
0.0599
AC:
15054
AN:
251388
AF XY:
0.0652
show subpopulations
Gnomad AFR exome
AF:
0.0108
Gnomad AMR exome
AF:
0.0245
Gnomad ASJ exome
AF:
0.0935
Gnomad EAS exome
AF:
0.0694
Gnomad FIN exome
AF:
0.0334
Gnomad NFE exome
AF:
0.0635
Gnomad OTH exome
AF:
0.0653
GnomAD4 exome
AF:
0.0611
AC:
89264
AN:
1461032
Hom.:
3076
Cov.:
32
AF XY:
0.0632
AC XY:
45971
AN XY:
726854
show subpopulations
African (AFR)
AF:
0.0104
AC:
347
AN:
33472
American (AMR)
AF:
0.0263
AC:
1177
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0910
AC:
2376
AN:
26124
East Asian (EAS)
AF:
0.0570
AC:
2263
AN:
39698
South Asian (SAS)
AF:
0.111
AC:
9559
AN:
86220
European-Finnish (FIN)
AF:
0.0358
AC:
1910
AN:
53416
Middle Eastern (MID)
AF:
0.109
AC:
626
AN:
5750
European-Non Finnish (NFE)
AF:
0.0606
AC:
67293
AN:
1111266
Other (OTH)
AF:
0.0615
AC:
3713
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
4109
8218
12327
16436
20545
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2498
4996
7494
9992
12490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0472
AC:
7192
AN:
152254
Hom.:
191
Cov.:
32
AF XY:
0.0466
AC XY:
3472
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0120
AC:
498
AN:
41568
American (AMR)
AF:
0.0386
AC:
591
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0951
AC:
330
AN:
3470
East Asian (EAS)
AF:
0.0815
AC:
423
AN:
5188
South Asian (SAS)
AF:
0.103
AC:
496
AN:
4816
European-Finnish (FIN)
AF:
0.0347
AC:
368
AN:
10600
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.0637
AC:
4329
AN:
68006
Other (OTH)
AF:
0.0546
AC:
115
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
341
683
1024
1366
1707
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0573
Hom.:
100
Bravo
AF:
0.0448
Asia WGS
AF:
0.0640
AC:
223
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Oct 30, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.0080
DANN
Benign
0.46
PhyloP100
-3.6
Mutation Taster
=23/77
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41304647; hg19: chr20-47569226; COSMIC: COSV64211288; API